To provide a potent and low-toxic treatment modality for HCC, transferrin-guided polymersomal doxorubicin (Tf-Ps-Dox) was fabricated with controlled transferrin density, small size, and high drug loading through ligand postmodification strategy by Wei et al. Here, TF is linked to hepatocellular carcinoma.